Cargando…
MORC4 Promotes Chemoresistance of Luminal A/B Breast Cancer via STAT3-Mediated MID2 Upregulation
PURPOSE: MORC4 has recently been characterized as a breast cancer-associated anti-apoptotic oncoprotein. In the current study, we explored its downstream regulation in luminal A/B breast tumors. MATERIALS AND METHODS: Bioinformatic prediction was performed using data from The Cancer Genome Atlas (TC...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367747/ https://www.ncbi.nlm.nih.gov/pubmed/32764967 http://dx.doi.org/10.2147/OTT.S260509 |